In the absence of Hsf1, the development of MLL-AF9 leukemia in vivo was significantly delayed (Fig. 1a), suggesting that HSF1 is required for the initiation of MLL-AF9–induced AML. This evidence concerns the gene KMT2A and acute myeloid leukemia.